VitaNova Life Sciences Corporation Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
VitaNova Life Sciences Corporation (VNOV) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $15.19 thousand for the 12-month period ending 2020-04-30, per its 10-K filed 2020-08-05.
Discontinued › Notes › Income Taxes
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2020-08-05
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2020-04-30 was $5.53K.
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2020-01-31 was $1.39K.
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2019-10-31 was $4.10K.
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2019-07-31 was $4.18K.
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $15.19K, a 31.86% decline from fiscal 2019.
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $22.29K, a 1110.31% increase from fiscal 2018.
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $1.84K, a 24.51% decline from fiscal 2017.
- VitaNova Life Sciences Corporation valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $2.44K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|---|
| 2020-04-30 | $5.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-05 | $6.92K derived: sum of 2 quarters · filed 2020-08-05 | $11.02K derived: sum of 3 quarters · filed 2020-08-05 | $15.19K 10-K · filed 2020-08-05 |
| 2020-01-31 | $1.39K 10-Q · filed 2020-03-20 | $5.48K derived: sum of 2 quarters · filed 2020-03-20 | $9.66K 10-Q · filed 2020-03-20 | |
| 2019-10-31 | $4.10K 10-Q · filed 2019-12-06 | $8.28K 10-Q · filed 2019-12-06 | ||
| 2019-07-31 | $4.18K derived: 10-K 12 month − 3 quarters · filed 2020-08-05 | |||
| 2019-04-30 | $22.29K 10-K · filed 2020-08-05 | |||
| 2018-04-30 | $1.84K 10-K · filed 2018-07-17 | |||
| 2017-04-30 | $2.44K 10-K · filed 2018-07-17 |